Cobalt(III) Complexes of Some Antimalarial Drugs: Synthesis, Characterization, and in vitro Antiprotozoal Studies
- 10 May 2010
- journal article
- research article
- Published by Taylor & Francis in Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry
- Vol. 40 (4) , 273-278
Abstract
Cobalt(III) complexes of the antimalarial drugs amodiaquine, chloroquine, quinacrine and trimethoprim are presented. The complexes were characterized by elemental analyses, conductance, magnetic susceptibility measurement, IR and electronic spectroscopies. Their in vitro antiplasmodial and antitrypanosomal activity against Trypanosoma cruzi, L. donovani, T. b. rhodesiense and the resistant strain of Plasmodium falciparum showed that the cobalt(III) complexes of quinacrine, [CoQNC(en)2Cl]Cl2 and amodiaquine, CoAQ(en)2Cl]Cl2 are more active than chloroquine against the resistant strain of P. falciparum.Keywords
This publication has 28 references indexed in Scilit:
- Antiplasmodial and antitrypanosomal activities of aminobicyclo[2.2.2]octyl ω-aminoalkanoatesEuropean Journal of Medicinal Chemistry, 2009
- Current Status of Malaria ControlCurrent Medicinal Chemistry, 2005
- MalariaThe Lancet, 2005
- The trypanosomiasesThe Lancet, 2003
- Eflornithine for the treatment of human African trypanosomiasisParasitology Research, 2003
- Resurrecting the resurrection drugNature Medicine, 2002
- Malaria in 2002Nature, 2002
- Clinical status and implications of antimalarial drug resistanceMicrobes and Infection, 2002
- The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burdenThe American Journal of Tropical Medicine and Hygiene, 2001
- The economic burden of malariaThe American Journal of Tropical Medicine and Hygiene, 2001